HLA expression tied to penile cancer outcomes

April 20, 2015
HLA expression tied to penile cancer outcomes

(HealthDay)—Human leukocyte antigen (HLA) expression appears to be tied to clinical outcomes in penile cancer, according to a study published in the April issue of The Journal of Urology.

Rosa S. Djajadiningrat, M.D., from the Netherlands Cancer Institute in Amsterdam, and colleagues constructed tissue microarrays from tissue blocks from 168 patients who underwent surgical resection between 2000 and 2009. HLA expression was determined using immunohistochemical staining (using classic and nonclassic molecules), and expression was scored semiquantitatively.

The researchers found that complete and partial loss of total classic HLA class I were seen in 32 and 50 percent of cases, respectively. Up-regulation of HLA-E and G was seen in 16 and 13 percent, respectively. Partial HLA-A loss was significantly associated with decreased survival overall (hazard ratio, 2.3) and in human papillomavirus-negative patients alone (hazard ratio, 3.4), when adjusting for relevant clinical parameters. Survival was not tied to abnormal HLA-B/C, E, or G .

"Complete understanding of the mechanisms and relevance of HLA down-regulation and immune evasion in regard to the clinical outcome will contribute to the future design of immunotherapy interventions," the authors write.

Explore further: Aspirin use appears linked with improved survival after colon cancer diagnosis

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Aspirin use appears linked with improved survival after colon cancer diagnosis

March 31, 2014
Taking low doses of aspirin (which inhibits platelet function) after a colon cancer diagnosis appears to be associated with better survival if the tumor cells express HLA class I antigen.

New study challenges link between HLA class I hyperexpression in pancreas and type 1 diabetes

January 6, 2015
The cause of type 1 diabetes remains unknown. Several studies using immunohistochemistry (IHC) have independently reported hyperexpression of human leukocyte antigen (HLA) class I on pancreatic islet cells in young patients ...

Particular donor genotype lowers leukemia relapse rate

August 30, 2012
(HealthDay)—Patients with acute myeloid leukemia who receive a stem cell transplant from a donor with activating killer-cell immunoglobulin-like receptor (KIR) genotype KIR2DS1, which has ligand specificity for human leukocyte ...

An unusual version of a gene appears to protect against enteric fever

April 15, 2015
A study looking for links between genes and susceptibility to enteric fever has found that people who carry a specific version of a gene are nearly five times less likely to have the disease. This finding by an A*STAR-led ...

New research shows how aspirin may act on blood platelets to improve survival in colon cancer patients

September 30, 2013
Researchers believe they have discovered how aspirin improves survival in patients diagnosed with colon cancer, the 2013 European Cancer Congress (ECC2013) [1] heard today (Monday).

Transplant success tied to naturally high levels of powerful immune molecule package

April 28, 2014
Patients with highest levels of the most powerful version of the immune molecule HLA-G appear to have the lowest risk of rejecting their transplanted kidney, researchers report.

Recommended for you

Research could help fine-tune cancer treatment

May 25, 2018
Cancer therapies that cut off blood supply to a tumour could be more effective in combination with existing chemotherapeutic drugs—according to new research from the University of East Anglia.

Increasing physical activity linked to better immunity in breast cancer patients, study finds

May 25, 2018
A new study from the University of Toronto's Faculty of Kinesiology & Physical Education has found that moderate to vigorous physical activity may help regulate the levels of C-reactive protein – an important biomarker ...

Fully reprogrammed virus offers new hope as cancer treatment

May 25, 2018
A cancer treatment that can completely destroy cancer cells without affecting healthy cells could soon be a possibility, thanks to research led by Cardiff University.

Study finds gut microbiome can control antitumor immune function in liver

May 24, 2018
Scientists have found a connection between bacteria in the gut and antitumor immune responses in the liver. Their study, published May 25 in Science, was led by researchers in the Center for Cancer Research (CCR) at the National ...

Low-fat diet tied to better breast cancer survival

May 24, 2018
(HealthDay)—Breast cancer patients who adopted a low-fat diet were more likely to survive for at least a decade after diagnosis, compared to patients who ate fattier fare, new research shows.

A cascade of immune processes offers insights to triple-negative breast cancer

May 24, 2018
Cancer is crafty. To survive and thrive, tumors find a way of thwarting our body's natural systems.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.